PepLib

Zhuzhou, China · Founded 2017 · Privately Held (backing)

Developer of peptide-leading drugs intended to serve the medical sector in China. PepLib is based in Zhuzhou, China and was founded in 2017. Its last reported valuation was $86.1 million in Jul 2019. It has raised $62.1 million.

Last reported valuation
$86.1M
Oct 2026
Priced at
—
Total raised
$62.1M
Last round
—

Who backs PepLib?

16 investors
InvestorType
Cowin CapitalVenture capital
Fortune CapitalVenture capital
CDH InvestmentsPE / buyout
Legend StarVenture capital
CAS Investment ManagementVenture capital
Xingxiang Investment Holding GroupOther
Hunan High-Tech Investment GroupOther
Honghui CapitalVenture capital
Zhuzhou SAH Innovation & Entrepreneur InvestmentOther
ASB VenturesOther
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PepLib investors

16 investors are on record for PepLib, including Cowin Capital, Fortune Capital, CDH Investments and Legend Star. By type, the record holds 5 venture capital firms and 1 private equity firm.

Free account
More of PepLib with a free account
  • ·The complete investor list: 16 names
  • ·Watch PepLib: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like PepLib. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View